ImmuneWalk Therapeutics
PrivateLast Round
Seed
May 7, 2025
Total Funding Raised
$7M
Company Overview
ImmuneWalk Therapeutics is a biotechnology company that develops novel monoclonal antibody therapies for chronic inflammatory diseases by targeting monocyte migration.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ImmuneWalk Therapeutics Comparables
Compare ImmuneWalk Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Dren Bio | 74% | |
| Ensho Therapeutics | 74% | |
| Roche Holding | 70% |
ImmuneWalk Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 7, 2025 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- May 7, 2025
$7M raised in Seed round.
- Sep 12, 2024
Grew 100% QoQ, from 3 to 6 employees.
ImmuneWalk Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ImmuneWalk Therapeutics's valuation, stock price, and market status.
Is ImmuneWalk Therapeutics a public or private company?
ImmuneWalk Therapeutics is a private company.
What is the current stock price of ImmuneWalk Therapeutics?
ImmuneWalk Therapeutics is a private company with no public stock price. Caplight tracks ImmuneWalk Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is ImmuneWalk Therapeutics worth (valuation)?
Valuation information for ImmuneWalk Therapeutics is not publicly available.
Can I buy ImmuneWalk Therapeutics stock?
ImmuneWalk Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ImmuneWalk Therapeutics's last funding round?
ImmuneWalk Therapeutics's most recent funding round was Seed on May 7, 2025.
Who are the main investors in ImmuneWalk Therapeutics?
Investor information for ImmuneWalk Therapeutics is not publicly disclosed.
Will ImmuneWalk Therapeutics IPO soon?
No public IPO plans have been announced for ImmuneWalk Therapeutics.
How can I track ImmuneWalk Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ImmuneWalk Therapeutics's secondary market activity and sign up for updates.